AAX Biotech was selected as the winner of the ๐ก๐ผ๐ฟ๐ฑ๐ถ๐ฐ ๐ฆ๐๐ฎ๐ฟ ๐ฎ๐ฌ๐ฎ๐ฒ ๐ฃ๐ถ๐๐ฐ๐ต ๐๐ผ๐บ๐ฝ๐ฒ๐๐ถ๐๐ถ๐ผ๐ป ๐ช๐ถ๐ป๐ป๐ฒ๐ฟ at NLSDays 2026, held in Stockholm on September 8โ9 2026.
Our CEO/CSO Daniel X. Johansson pitched in a field of 13 other Nordic SMEs that represent the cutting edge of life science, from groundbreaking medical devices to life-saving therapeutics.
In the end, Daniel convinced the jury of seasoned investors of AAX Biotechโs technologies, Opti-mAbยฎ and Seqitopeยฎ, and their market potential.
The jury awarded the prize to AAX Biotech for โa highly sophisticated, high impact solution with a clear business caseโ.
You can read more on the Nordic Star Pitch Competition and NLSDays in their press release.